Mineralys Therapeutics Inc. has granted inducement stock option awards covering 33,504 shares and inducement restricted stock unit awards covering 25,128 shares of its common stock to two new non-executive employees. The stock options will vest over four years, with 25% vesting on the first anniversary of the vesting commencement date, February 9, 2026, and the remainder vesting in equal monthly installments thereafter. The restricted stock units will also vest over four years, with 25% vesting on each anniversary of the vesting commencement date. These awards were made under the company’s 2025 Employment Inducement Incentive Award Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9653404) on February 12, 2026, and is solely responsible for the information contained therein.